Open AccessCognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation
Author(s) -
Zev M. Nakamura,
Allison M. Deal,
Donald L. Rosenstein,
Laura J. Quillen,
Stephanie A. Chien,
William A. Wood,
Thomas C. Shea,
Eliza M. Park
Publication year - 2020
Publication title -
supportive care in cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.133
H-Index - 112
eISSN - 1433-7339
pISSN - 0941-4355
DOI - 10.1007/s00520-020-05697-2
Subject(s) - medicine , psychosocial , montreal cognitive assessment , transplantation , hematopoietic stem cell transplantation , cognition , comorbidity , psychiatry , cognitive impairment
Cognitive impairment is common and consequential in patients with cancer who undergo allogeneic hematopoietic stem cell transplantation (HSCT). However, there is no standard of care for evaluating cognition in patients prior to or after receiving HSCT, and it is not known which patients are at highest risk for cognitive impairment. The objectives of this study were to describe cognitive function in patients prior to allogeneic HSCT and identify demographic, disease-related, and psychosocial factors associated with cognitive function.